Stem-cell institute gets a new president, but its management challenges haven’t gone away

Stem-cell institute gets a new president, but its management challenges haven’t gone away

California’s $3 billion stem-cell agency, which has been without a permanent leader since the end of April, finally filled that void yesterday by naming Alan Trounson as its second president.

Hopes are obviously high that the widely respected Australian scientist, pictured at left, can bring… Continue Reading

California’s stem-cell management disarray

California’s stem-cell management disarray

(CORRECTED: See below.)

These should be the best of times for California’s $3 billion stem-cell program. Lawsuits that barred the institute from spending its vast sums have been dismissed, serious money has started to flow to scientists, and a $227 million capital-spending project that will build new… Continue Reading

Health and science roundup: Amgen, generic biologics, the origins of white people and more

Health and science roundup: Amgen, generic biologics, the origins of white people and more

(Note: This item has been copied over to the Life Sciences page from its original location on the VentureBeat main page. To view it in its original context, with comments, click here.)

Amgen’s anemia rollercoaster — Biotechnology titan Amgen may have dodged a bullet when a study… Continue Reading

Stem cell institute sees leaders leave in exhaustion

Stem cell institute sees leaders leave in exhaustion

Zach Hall, president and top scientist at California’s $3 billion stem cell institute said he will resign from the agency within the next six months.

He cited personal reasons, but he often butted heads with Robert Klein, chairman of the board. The institute is also battling… Continue Reading